Why did Xanadu Quantum Technologies (Nasdaq: XNDU) fall so sharply in September despite announcing favorable developments? The most plausible reported catalyst was the September 22 expiry of a post-listing lockup, which raised concern that more shares could become available for resale. The timing supports that explanation, but does not prove lockup expiry alone caused the full monthly decline.
How steep was XNDU’s September decline?
The Motley Fool reported on October 4, 2026, that XNDU fell 56.2% in September, attributing the monthly figure to S&P Global Market Intelligence. The same article reported that the stock had already dropped 32% between the end of August and September 21, then fell 27.5% on September 22.
| Period | Reported move | Attribution |
|---|---|---|
| September 2026 | Down 56.2% | The Motley Fool, October 4, 2026, citing S&P Global Market Intelligence |
| End of August through September 21, 2026 | Down 32% | The Motley Fool, 2026 |
| September 22, 2026 | Down 27.5% | The Motley Fool, 2026 |
These are figures as reported by The Motley Fool, not an independently recalculated price series. The timing makes the September 22 event important, but the figures alone cannot establish why every seller acted or account for the entire month’s decline.
Why did the lockup expiry matter?
More potential sellers can weigh on a thinly traded stock
A post-listing lockup restricts certain early holders from selling shares for a set period. When that restriction expires, eligible holders may be able to sell, subject to applicable securities laws and other restrictions. Investors can anticipate that possibility before the expiry date and mark down a stock if they expect a larger supply of shares to meet demand.
Recommended Free Tools
#1 Best Overall
Benzinga’s September 22 account identified the lockup expiry that day and reported the sharp daily move. The Motley Fool’s chronology says the stock had already lost 32% through September 21 before the additional 27.5% decline on the expiry date. Together, these reports support lockup-related selling pressure as a likely catalyst—not proof that all the shares became available, that holders sold them, or that the lockup was the sole cause of the monthly fall.
Share classes make the reported float estimate uncertain
Benzinga reported that roughly 255 million shares entered the public float. That estimate should not be treated as a confirmed count of newly tradable shares. Xanadu’s Form 20-F identifies XNDU as its Class B subordinate voting share and reports that, as of April 2, 2026, 255,226,928 Class A multiple voting shares and 43,284,436 Class B subordinate voting shares were outstanding. Class A shares and the public float are not interchangeable, and those filing figures do not establish that roughly 255 million shares became freely tradable when the lockup expired.
Rank #2
Did Xanadu’s financing add to share-supply concerns?
There was also an existing financing context. In its Q2 2026 filing, filed August 5, Xanadu reported issuing 5,467,524 Class B shares through its synthetic at-the-market facility during the quarter, for net proceeds of $67.154 million. As of June 30, up to 24,532,476 shares of capacity remained under the facility.
An at-the-market facility gives a company a way to issue shares over time, which can contribute to investor concern about dilution. But those figures describe Q2 financing and remaining capacity as of June 30; they do not show that the facility caused September’s decline or establish that all remaining capacity was used.
Do these 3 things before closing this tab:
1Scan for outdated or missing drivers - takes under a minute2Clear out junk files and repair common Windows errors3Fix the driver behind crashes, sound loss and screen glitchesWhat favorable developments did Xanadu announce?
The sell-off happened in a month that included several positive company announcements. Their potential is distinct from proof of commercial sales, delivered products, or near-term revenue.
- September 9 — ASML: Xanadu announced a collaboration with ASML to explore lithography processes for photonic quantum hardware. In the company release, founder and CEO Dr. Christian Weedbrook said, “Fault tolerance and error correction are arguably the most important technical objectives for the quantum computing industry.” This was his statement about the work, not independent confirmation that those objectives had been achieved.
- September 10 — AMD and Backline: Xanadu released Backline, open-source software developed with AMD. The announcement demonstrates a software collaboration and release; it does not by itself establish a commercial revenue stream or the performance of a future quantum computer.
- September 29 — Bluefors: Xanadu announced a multi-million-dollar collaboration with Bluefors on a cryogenic prototype. The announced project is a development effort, not evidence that a commercial-scale system has been delivered.
These announcements help explain why the month’s direction may seem surprising, but favorable technical news does not necessarily outweigh concerns about share supply, dilution, execution risk, or valuation. Nor do the sources establish that investors’ September selling was a direct reaction to any one announcement.
Did an insider plan cause September selling?
No September sales are established by Xanadu’s September 30 disclosure. The company said COO Rafal Janik had adopted a securities disposition plan that could permit sales of up to 312,914 shares, starting no earlier than December 29, 2026. The plan concerns possible future transactions; it is not evidence that those shares were sold in September.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What does the decline say about Xanadu’s investment risk?
A sharp one-month loss is a reminder that XNDU is a single-company exposure to a developing technology business, not a diversified way to invest in quantum computing. Xanadu’s Form 20-F describes significant development barriers, a history of operating losses and negative cash flows, and uncertainty about reaching profitability. Partnerships and technical projects may be meaningful milestones, but they do not remove those risks or guarantee commercialization.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Best Value
Investors evaluating the stock can separate three questions: whether they believe Xanadu can meet its technical goals, whether it can fund development without unacceptable dilution, and whether the shares’ price reflects the risks and uncertainty. Someone seeking broader exposure rather than dependence on one company could compare diversified funds with an individual stock, while checking each fund’s holdings, fees, and availability. That comparison is not a recommendation to buy XNDU or any fund.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
